Viatorr Endoprosthesis
Payments companies reported to CMS as associated with Viatorr Endoprosthesis. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Viatorr Endoprosthesis, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Viatorr Endoprosthesis
These are the largest totals companies reported as associated with Viatorr Endoprosthesis. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Wael Saad | Ann Arbor, MI | Vascular & Interventional Radiology | $55,870.96 |
| Edward Lee | Los Angeles, CA | Vascular & Interventional Radiology | $52,785.00 |
| William Gray | Wynnewood, PA | Interventional Cardiology | $38,860.00 |
| Ellen Dillavou | Raleigh, NC | Vascular Surgery | $34,200.00 |
| Venita Chandra | Palo Alto, CA | Vascular Surgery | $33,801.88 |
| Darren Schneider | Philadelphia, PA | Vascular Surgery | $19,500.00 |
| Hector Ferral | Evanston, IL | Vascular & Interventional Radiology | $17,294.07 |
| Brett Fortune | Miami, FL | Hepatology | $16,977.98 |
| Steven Abramowitz | Washington, DC | Vascular Surgery | $14,960.00 |
| Barry Katzen | Miami, FL | Diagnostic Radiology | $14,377.62 |
Prescribed Viatorr Endoprosthesis?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.